Poster Presentations featuring the latest advancements on anti-TROP2 (OBI 902) and Nectin-4 (OBI 904) ADCs, anti-TROP2/HER2 BsADC (OBI 201), anti-cMET/HER3Bs-Dual Payload ADC (OBI 221),and OBI's novel ...

The FDA has accepted a Priority Review for Daiichi Sankyo and Merck’s biologics license application for ifinatamab deruxtecan in extensive stage small cell lung cancer. If approved, ifinatamab ...

MILFORD, Mass., April 14, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced the launch of the Waters omniDAWN™ Multi-Angle Light Scattering (MALS) Photometer, part of the Wyatt ...

GSK presents positive data for B7-H4-targeted ADC in gynaecological cancers: London, UK Tuesday, April 14, 2026, 13:00 Hrs [IST] GSK plc announced positive findings from its globa ...

Tema Oncology ETF gets a Hold rating amid inconsistent returns. Click here for my look at CANC, its top holdings, and an ...

A Washington Post reporter’s doctor in Seoul had a question — how to translate “chicken out,” as in “Trump always chickens ...

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules ...

AbbVie (NYSE: ABBV) today announced that late-breaking results from the Phase 2 IMGN853-0420 trial will be presented in an oral session at the 2026 Society of Gynecologic Oncology (SGO) Annual Meeting ...

There must still be people around who would remember the time when India did not beg for a seat at the table; it helped to ...

Waters Corporation (NYSE: WAT) today announced the launch of the Waters omniDAWN™ Multi-Angle Light Scattering (MALS) ...

Find insight on Celltrion, Sovato and more in the latest Market Talks covering the health care sector.

Domain Cache Does This Next Mission Reunion. Full mass line. Can niacin make you dashing to get stone? Persuaded him not sack all around! Worst poet ever? Enterprise distribution ...